NCBI National Center for Biotechnology Information |
4DFF: The SAR development of dihydroimidazoisoquinoline derivatives as phosphodiesterase 10A inhibitors for the treatment of schizophrenia | ||||||||||||||||||
* Click molecule labels to explore molecular sequence information.
|